Blood thinner comparison for heart procedures in high bleeding risk patients
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two blood thinners, bivalirudin and heparin, given during a heart procedure to open blocked arteries (PCI). It aims to find which one is safer for people at high risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a recent heart attack or unstable angina and are scheduled for a procedure to open blocked heart arteries (PCI).
- You are considered at high risk for bleeding based on specific medical criteria.
- You have not had heart surgery (CABG) or a stent procedure (PCI) in the last 6 months.
- You are not in cardiogenic shock and do not have an aortic dissection.
- You are not allergic to the study drugs or contrast dye.
- You are expected to live more than 12 months and can follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best time to give a standard blood thinner (heparin) during a heart procedure called angioplasty, which opens blocked heart arteries through a wrist artery. It may help reduce bleeding or clotting risks.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
This trial is testing whether a newer type of blood thinner (called a NOAC) can be used safely right after a heart attack or related event, in addition to the standard two antiplatelet medicines. It focuses on patients who have higher risk signs, like elevated D-dimer levels or a higher PARIS risk score, to see if this approach is safe and effective at preventing future heart problems.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This study compares two blood-thinning medicines used during a heart procedure (PCI) after you've already received clot-busting drugs. The goal is to see which one helps prevent more blockages and complications.
This trial studies which blood-thinner (antiplatelet) strategy is safest and most effective for people at high risk of bleeding after a procedure called PCI. It also looks at longer-term outcomes and whether adjusting treatment can improve safety without losing heart protection.
Hear when a new Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.